Annual Report 2003 - Hannover Re
Annual Report 2003 - Hannover Re
Annual Report 2003 - Hannover Re
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Management report<br />
life and health reinsurance<br />
<strong>Hannover</strong> Life <strong>Re</strong><br />
Australasia is the largest<br />
life reinsurer in Australia<br />
Other international markets<br />
Australia and New Zealand<br />
Our subsidiary <strong>Hannover</strong> Life <strong>Re</strong> Australasia<br />
operates in Australia and New Zealand. In the<br />
year under review it further consolidated its position<br />
as the Australian market's leading life reinsurer.<br />
The bulk of the business written is riskoriented,<br />
with concentrations in life, disability<br />
annuities and critical illness policies. Direct group<br />
life business is a particular speciality in which the<br />
company has made a name for itself as one of<br />
the leading providers of occupational pension<br />
schemes in Australia.<br />
Gross premiums grew by 28.8% in the year<br />
under review to EUR 201.1 million (EUR 156.1<br />
million). Profitability was again gratifying thanks<br />
to a favourable overall claims experience and a<br />
20.8% increase in investment income. The operating<br />
profit (EBIT) climbed by 29.2% to EUR<br />
12.2 million (EUR 9.4 million).<br />
Africa<br />
On this continent we concentrate on the<br />
English-speaking markets of southern Africa, i.e.<br />
sub-Saharan Africa, with a clear focus on South<br />
Africa. As the second-largest reinsurer in Africa,<br />
our subsidiary <strong>Hannover</strong> Life <strong>Re</strong> Africa in Johannesburg<br />
writes a risk-oriented portfolio of life<br />
and health business.<br />
Since results in the previous two years –<br />
particularly in health business – had failed to<br />
meet our expectations, we decided to implement<br />
extensive portfolio rehabilitation. Gross premium<br />
income grew only slightly to EUR 67.5 million<br />
(EUR 63.3 million). Following a positive result in<br />
the previous year, the year under review closed<br />
with an operating loss (EBIT) of EUR 6.3 million.<br />
markets of Malaysia and Singapore as well as in<br />
China, where we were able to conclude our first<br />
financing transaction with a major client.<br />
The premium volume grew by 6.8% to<br />
EUR 47.0 million, with Hong Kong, Japan and<br />
Malaysia making the most prominent contributions.<br />
The claims experience varied widely in the<br />
year under review. As had also been the case in<br />
the previous year, an important Japanese life<br />
treaty unexpectedly produced an above-average<br />
number of claims which not only burdened<br />
us with regular losses but also compelled us to<br />
establish an additional premium deficiency reserve.<br />
The claims experience in Greater China, on<br />
the other hand, was very good, and in the ASEAN<br />
markets it was excellent.<br />
In China our goal is to significantly expand<br />
our position in the medium term, and in the<br />
fourth quarter of <strong>2003</strong> we therefore decided to<br />
file a licensing application with the China Insurance<br />
<strong>Re</strong>gulatory Commission (CIRC) for operation<br />
of a branch in Shanghai. We expect this<br />
branch to commence business activities in the<br />
first half of 2005.<br />
Asia<br />
The Asian markets are currently served by<br />
the two branches of <strong>Hannover</strong> Life <strong>Re</strong> International<br />
in Kuala Lumpur and Hong Kong. Our<br />
efforts to acquire new business in the year under<br />
review made considerable progress in the ASEAN<br />
42